Itopri may be used for gastrointestinal symptoms associated with chronic gastritis, including:
In the event of an excessive dose, medical evaluation is required. Treatment generally consists of appropriate supportive and symptomatic management. Gastric decontamination may be considered by healthcare professionals depending on the circumstances.
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Itopride Hydrochloride works mainly by blocking dopamine D2 receptors and inhibiting acetylcholinesterase. These actions increase the availability and activity of acetylcholine in the gastrointestinal tract.
The increased cholinergic activity promotes gastrointestinal movement, increases lower esophageal sphincter pressure, stimulates stomach contractions, speeds up gastric emptying, and improves coordination between the stomach and duodenum. These effects help food move more efficiently through the digestive tract.
Itopri Tablet is a gastrointestinal medicine used to relieve symptoms associated with chronic gastritis and impaired gastric motility. It may help improve symptoms such as abdominal fullness or bloating, upper abdominal discomfort, loss of appetite, heartburn, nausea, and vomiting.
The usual adult dose is:
50 mg orally three times daily, preferably before meals.
The dosage may be adjusted according to the patient's age, symptoms, and response to treatment.
Older adults may be more susceptible to adverse effects because of age-related physiological changes. They should therefore be monitored carefully. If significant side effects occur, the doctor may reduce the dose or discontinue treatment.
The safety and effectiveness of itopride have not been adequately established in patients below 18 years of age. Therefore, its use in children and adolescents is generally not recommended.
Rarely, serious allergic or anaphylactoid reactions may occur. Treatment should be stopped, and appropriate medical attention sought if symptoms such as:
develop during treatment.
Liver dysfunction or jaundice may occur in rare cases and may be associated with elevated liver enzymes such as AST, ALT, or GGT. Treatment should be discontinued and medical evaluation obtained if signs of liver problems develop.
Itopri should be used cautiously with medicines that have anticholinergic effects, such as:
These medicines can reduce gastrointestinal movement and may therefore decrease the prokinetic effect of itopride.
Always inform your doctor about all prescription medicines, over-the-counter products, and supplements you are taking.
This includes situations such as:
Itopri increases the activity of acetylcholine and should therefore be used cautiously in susceptible patients.
If gastrointestinal symptoms do not improve, prolonged continuous use without medical reassessment should be avoided.
For tablets supplied in a press-through package (PTP), remove the tablet from the blister before swallowing. The blister sheet itself should never be swallowed because its sharp edges may injure the esophagus or gastrointestinal tract and can potentially cause serious complications.
The safety of itopride during pregnancy has not been fully established. It should only be considered during pregnancy when the expected therapeutic benefit clearly outweighs the potential risk.
There is limited information regarding the excretion of itopride into human breast milk. Because sufficient clinical experience is lacking, its use during breastfeeding is generally not recommended unless specifically advised by a healthcare professional.
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.